Table 3.
Mean hourly activity data shown for the different analysis contrasts, presented as either arithmetic or percentage change from baseline.
| Contrast | Arithmetic change | Relative change (%) | ||||
|---|---|---|---|---|---|---|
| Estimate | SE | P value | Estimate | SE | P value | |
| C1 | 116.4 | 80.4 | 0.15 | 5.65 | 4.78 | 0.24 |
| C2 | 75.1 | 87.7 | 0.39 | 3.54 | 5.28 | 0.50 |
| C3 | − 23.2 | 60.3 | 0.70 | 1.25 | 3.38 | 0.71 |
Estimate = change from baseline in mean hourly activity counts with robenacoxib relative to placebo. Estimate = change from baseline in hourly activity counts with robenacoxib relative to placebo.
C1 contrast 1 = treatment group PP compared against groups RR and RP following 3 weeks of treatment, C2 contrast 2 = treatment group PP compared against group RR following 6 weeks of treatment, C3 contrast 3 = treatment group RP compared against RR for change in activity between weeks 3 and 6 of treatment, SE standard error, P placebo, R robenacoxib.
*P values test whether the contrast is significantly different from zero.